RBC Capital Maintains Sector Perform on Danaher, Raises Price Target to $334
RBC Capital analyst Deane Dray maintains Danaher (NYSE:DHR) with a Sector Perform and raises the price target from $332 to $334.
10 Biggest Price Target Changes For Friday
Keybanc cut Snap Inc. (NYSE: SNAP) price target from $90 to $85. Snap shares fell 20.6% to $59.61 in pre-market trading.
Keybanc Maintains Overweight on Danaher, Raises Price Target to $345
Keybanc analyst Paul Knight maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $315 to $345.
Danaher: Q3 Earnings Insights
Danaher (NYSE:DHR) reported its Q3 earnings results on Thursday, October 21, 2021 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Danaher beat their estimated earnings by 11.16%, which surprised analysts.
Danaher’s Q3 Earnings Beats Street Estimates
Danaher Corporation (NYSE:DHR) logged Q3 adjusted EPS of $2.39 up 39% Y/Y, surpassing the estimate of $2.15. Sales increased 23% to…
Earnings Scheduled For October 21, 2021
Companies Reporting Before The Bell
• Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million.
Here’s How Much $100 Invested In Danaher 15 Years Ago Would Be Worth Today
Danaher (NYSE:DHR) has outperformed the market over the past 90 days by 10.15%, generating a 10.28% return for its investors over the time period. Now, given this information, it may seem like price appreciation alone is the best way to have made money on this stock, that's not actually the case.
Danaher’s Beckman Coulter Highlights Launch Of DxU Iris Workcell At AACC Annual Scientific Meeting & Clinical Lab Expo
Beckman Coulter today announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo. The DxU Iris Workcell is a fully automated system that streamlines urinalysis
Where Danaher Stands With Analysts
Danaher (NYSE:DHR) has observed the following analyst ratings within the last quarter: